Updated comprehensive review of natriuretic peptide biology (ANP, BNP, CNP, DNP, urodilatin), therapeutic applications (nesiritide, sacubitril concept), and cardiovascular disease biomarker/therapy roles.
Key findingUpdated natriuretic peptide review covering expanded family (ANP, BNP, CNP, DNP, urodilatin), therapeutic developments (nesiritide, neprilysin inhibit
What the researchers found
Updated natriuretic peptide review covering expanded family (ANP, BNP, CNP, DNP, urodilatin), therapeutic developments (nesiritide, neprilysin inhibition concept), and comprehensive cardiovascular biomarker and therapeutic applications — the 2008 state of the art.
Why it matters
Relevant for natriuretic-peptides, cardiovascular.
How the study worked
review study.
What this study cannot tell us
See abstract.
How to read the evidence
moderate evidence.
When this study was published
Published in 2008.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases.
American journal of hypertension, 21(7), 733-41
Citation
Rubattu, Speranza; Sciarretta, Sebastiano; Valenti, Valentina; Stanzione, Rosita; Volpe, Massimo. (2008). Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases.. American journal of hypertension, 21(7), 733-41. https://doi.org/10.1038/ajh.2008.174